Donate
|
Join/Renew
|
Store
|
Member Directory
|
My SNMMI
Search SNMMI.org
Search SNMMI Learning Center
Value Initiative
|
Physicians
|
Technologists
|
Scientists
|
Residents
|
Healthcare Provider
|
Patients
NEWS & PUBLICATIONS
News and Media
Newsletters
Journals
Books
MEMBERSHIP
Join/Renew
Benefits
Categories
Download a Member Application
Grants, Awards, and Scholarships
Access the Phantom Analysis Toolkit
Membership Directory
Chapters
Centers of Excellence
Councils
Member Spotlight
Women in Nuclear Medicine
SNMMI Fellow
SNMMI-TS Fellow
Council and Center Internships
EDUCATION
Learning Center
Webinars
MEETINGS & EVENTS
Calendar of Events
Webinars
2024 Annual Meeting
2024 Therapeutics Conference
2024 Mid-Winter Meeting
Nuclear Medicine & Molecular Imaging Week
ADVOCACY
Coding & Reimbursement
Legislative Efforts
Government Relations News
Radiopharmaceutical Supply News
USP 825
Technologist State Issues
Position Statements
FDA PET Drug Manufacturing Q&A
EVIDENCE & QUALITY
Clinical Guidelines and AUC
Quality
Quality and Patient Safety
Dose Optimization
About Quality & Practice
Dosimetry
RESEARCH
Clinical Trials Network
Radiopharmaceutical Therapy Central
Radiopharmaceutical Therapy Centers of Excellence
Preclinical Imaging
Nuclear Medicine Clinical Trial Group, LLC
Research: Learn More
ABOUT SNMMI
Strategic Plan
Bylaws & Procedures
Governance - SNMMI
Governance - SNMMI-TS
History
Grants, Awards, and Scholarships
Career Center
About Nuclear Medicine & Molecular Imaging
International Collaboration
Outreach
Support SNMMI
Contact Us
HOME
>
SEARCH
>
SEARCH RESULTS
Refine by Audience:
Physicians
(442)
Scientists
(395)
International
(228)
Media
(224)
Healthcare Provider
(211)
Patients
(176)
Selected filters:
Technologists
Displaying 61 to 70 of 622 records
Sort by:
Relevancy
Date Added
Page:
<< Prev
4
…
5
…
6
…
7
…
8
…
9
…
10
…
Next >>
FDA Approves New Pluvicto Production Facility in Indianapolis
– Jan 5, 2024
Today Novartis announced that it has received FDA approval for its radioligand therapy manufacturing facility in Indianapolis for commercial manufacturing of Pluvicto.
CMS Removes NCD 220.6.20 From Publication 100-03
– Jan 3, 2024
CMS removed NCD 220.6.20 from Publication 100-03, ending CED for PET beta amyloid imaging and permitting Medicare coverage determinations to be made by the Medicare Administrative Contractors.
Ga-68 FAPI PET Improves Detection and Staging of Pancreatic Cancer
– Dec 20, 2023
PET imaging with Ga-68 FAPI can more effectively detect and stage pancreatic cancer as compared with 18F-FDG imaging or contrast-enhanced CT, according to new research published in JNM. In addition, Ga-68 FAPI imaging paves the way for future targeted radiopharmaceutical therapies.
New PET Tracer Noninvasively Identifies Cancer Gene Mutation, Allows for More Precise Diagnosis and Therapy
– Dec 19, 2023
A novel PET imaging tracer has been proven to safely and effectively detect a common cancer gene mutation that is an important molecular marker for tumor-targeted therapy, according to research published in The Journal of Nuclear Medicine.
Uptake: Words of Wisdom from Recent Graduates
– Dec 15, 2023
Hang in there, students! Words of wisdom from recent graduates
HPRA December 2023 Newsletter
– Dec 14, 2023
SNMMI Health Policy and Regulatory Affairs Department released its December 2023 Newsletter. Highlights include updates on CMS HOPPS Rules, The FIND Act, and other legislative initiatives.
CMS Releases Final Rule on the Hospital Outpatient Prospective Payment System
– Dec 7, 2023
In early November, CMS released the Hospital Outpatient Prospective Payment System (OPPS) CY 2024 final rule.
SNMMI Releases New Edition of PET Study Guide
– Nov 29, 2023
SNMMI is pleased to announce the release of the third edition of its popular PET Study Guide. The updated version incorporates the latest innovations in imaging technology and FDA-approved PET radiopharmaceutical and imaging techniques and practices.
Journal of Nuclear Medicine Supplement Explores Nuclear Cardiology
– Nov 20, 2023
A new JNM supplement highlights the exciting new developments and opportunities for nuclear cardiology in the modern era of personalized cardiovascular medicine.
SNMMI Holds Joint Workshop with FDA on PET Drug Regulations
– Nov 16, 2023
On November 13 and 14, SNMMI co-hosted a workshop on PET drug manufacturing with the FDA.
Displaying 61 to 70 of 622 records
Page:
<< Prev
4
…
5
…
6
…
7
…
8
…
9
…
10
…
Next >>
Didn't find what you were looking for? Conduct a new search.